ECRE Stock Overview
Manufactures and sells basic chemicals, intermediate chemicals, and pharmaceuticals in Spain. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Ercros, S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €3.16 |
| 52 Week High | €3.16 |
| 52 Week Low | €3.16 |
| Beta | 1.08 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | 73.82% |
| 5 Year Change | -36.37% |
| Change since IPO | 704.07% |
Recent News & Updates
Recent updates
Shareholder Returns
| ECRE | GB Chemicals | GB Market | |
|---|---|---|---|
| 7D | 0% | -3.1% | 1.7% |
| 1Y | n/a | -19.8% | 9.0% |
Return vs Industry: Insufficient data to determine how ECRE performed against the UK Chemicals industry.
Return vs Market: Insufficient data to determine how ECRE performed against the UK Market.
Price Volatility
| ECRE volatility | |
|---|---|
| ECRE Average Weekly Movement | n/a |
| Chemicals Industry Average Movement | 5.5% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 10.4% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: ECRE has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine ECRE's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1817 | 1,343 | Antonio Zabalza Marti | www.ercros.es |
Ercros, S.A. manufactures and sells basic chemicals, intermediate chemicals, and pharmaceuticals in Spain. It operates through three segments: Chlorine Derivatives, Intermediate Chemicals, and Pharmacy. The Chlorine Derivatives segment produces ammonia, bioplastics, caustic potash and soda, chlorine, chloroisocyanurates, dicalcium phosphate, dichloroethane, hydrochloric acid, hydrogen peroxide, potassium carbonate, PVC compounds, sodium chlorate and chlorite, sodium hypochlorite, and vinyl chloride monomers.
Ercros, S.A. Fundamentals Summary
| ECRE fundamental statistics | |
|---|---|
| Market cap | €284.57m |
| Earnings (TTM) | €38.11m |
| Revenue (TTM) | €909.26m |
7.5x
P/E Ratio0.3x
P/S RatioIs ECRE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ECRE income statement (TTM) | |
|---|---|
| Revenue | €909.26m |
| Cost of Revenue | €631.74m |
| Gross Profit | €277.52m |
| Other Expenses | €239.41m |
| Earnings | €38.11m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
Feb 29, 2024
| Earnings per share (EPS) | 0.40 |
| Gross Margin | 30.52% |
| Net Profit Margin | 4.19% |
| Debt/Equity Ratio | 37.1% |
How did ECRE perform over the long term?
See historical performance and comparison